FDA issued a Warning Letter to SmithKline Beecham Limited on 6/30/2016 for a later inspection.
483 SmithKline Beecham Oct 2012

483 SmithKline Beecham Oct 2012

$119 - Not in Stock

FDA investigators audited the SmithKline Beecham - Worthing, United Kingdom facility and issued inspectional observations (via FDA 483) on 19 Oct 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Oct 2012
  • Location: Worthing, United Kingdom
  • FEI: 1000166776

Pre-Order Not Available